vs
Enact Holdings, Inc.（ACT）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是CORCEPT THERAPEUTICS INC的1.5倍（$312.7M vs $202.1M），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 3.6%），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 3.6%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
ACT vs CORT — 直观对比
营收规模更大
ACT
是对方的1.5倍
$202.1M
营收增速更快
CORT
高出7.5%
3.6%
两年增速更快
CORT
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.7M | $202.1M |
| 净利润 | — | $24.3M |
| 毛利率 | — | 98.7% |
| 营业利润率 | 71.3% | 2.2% |
| 净利率 | — | 12.0% |
| 营收同比 | 3.6% | 11.1% |
| 净利润同比 | — | -21.0% |
| 每股收益（稀释后） | $1.23 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTCORT
| Q4 25 | $312.7M | $202.1M | ||
| Q3 25 | $311.5M | $207.6M | ||
| Q2 25 | $304.9M | $194.4M | ||
| Q1 25 | $306.8M | $157.2M | ||
| Q4 24 | $301.8M | $181.9M | ||
| Q3 24 | $309.6M | $182.5M | ||
| Q2 24 | $298.8M | $163.8M | ||
| Q1 24 | $291.6M | $146.8M |
净利润ACTCORT
| Q4 25 | — | $24.3M | ||
| Q3 25 | — | $19.7M | ||
| Q2 25 | — | $35.1M | ||
| Q1 25 | — | $20.5M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $47.2M | ||
| Q2 24 | — | $35.5M | ||
| Q1 24 | — | $27.8M |
毛利率ACTCORT
| Q4 25 | — | 98.7% | ||
| Q3 25 | — | 97.8% | ||
| Q2 25 | — | 98.2% | ||
| Q1 25 | — | 98.5% | ||
| Q4 24 | — | 98.4% | ||
| Q3 24 | — | 98.4% | ||
| Q2 24 | — | 98.5% | ||
| Q1 24 | — | 98.3% |
营业利润率ACTCORT
| Q4 25 | 71.3% | 2.2% | ||
| Q3 25 | 67.4% | 4.9% | ||
| Q2 25 | 70.4% | 13.7% | ||
| Q1 25 | 68.9% | 2.2% | ||
| Q4 24 | 68.9% | 13.9% | ||
| Q3 24 | 74.1% | 25.5% | ||
| Q2 24 | 78.6% | 21.7% | ||
| Q1 24 | 70.6% | 20.1% |
净利率ACTCORT
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 9.5% | ||
| Q2 25 | — | 18.1% | ||
| Q1 25 | — | 13.1% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 25.9% | ||
| Q2 24 | — | 21.7% | ||
| Q1 24 | — | 18.9% |
每股收益（稀释后）ACTCORT
| Q4 25 | $1.23 | $0.20 | ||
| Q3 25 | $1.10 | $0.16 | ||
| Q2 25 | $1.11 | $0.29 | ||
| Q1 25 | $1.08 | $0.17 | ||
| Q4 24 | $1.05 | $0.25 | ||
| Q3 24 | $1.15 | $0.41 | ||
| Q2 24 | $1.16 | $0.32 | ||
| Q1 24 | $1.01 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $372.2M |
| 总债务越低越好 | $744.5M | — |
| 股东权益账面价值 | $5.4B | $647.8M |
| 总资产 | $6.9B | $836.7M |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTCORT
| Q4 25 | $582.5M | $372.2M | ||
| Q3 25 | $545.6M | $421.7M | ||
| Q2 25 | $616.0M | $342.2M | ||
| Q1 25 | $639.0M | $322.8M | ||
| Q4 24 | $602.8M | $383.3M | ||
| Q3 24 | $674.9M | $380.3M | ||
| Q2 24 | $711.3M | $473.2M | ||
| Q1 24 | $624.3M | $410.8M |
总债务ACTCORT
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | — |
股东权益ACTCORT
| Q4 25 | $5.4B | $647.8M | ||
| Q3 25 | $5.3B | $631.9M | ||
| Q2 25 | $5.2B | $635.8M | ||
| Q1 25 | $5.1B | $683.3M | ||
| Q4 24 | $5.0B | $679.6M | ||
| Q3 24 | $5.0B | $638.8M | ||
| Q2 24 | $4.8B | $596.2M | ||
| Q1 24 | $4.7B | $547.9M |
总资产ACTCORT
| Q4 25 | $6.9B | $836.7M | ||
| Q3 25 | $6.9B | $823.6M | ||
| Q2 25 | $6.8B | $801.7M | ||
| Q1 25 | $6.7B | $846.5M | ||
| Q4 24 | $6.5B | $840.6M | ||
| Q3 24 | $6.6B | $784.3M | ||
| Q2 24 | $6.3B | $714.6M | ||
| Q1 24 | $6.3B | $655.9M |
负债/权益比ACTCORT
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $724.5M | $38.4M |
| 自由现金流经营现金流 - 资本支出 | — | $38.4M |
| 自由现金流率自由现金流/营收 | — | 19.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.58× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACTCORT
| Q4 25 | $724.5M | $38.4M | ||
| Q3 25 | $192.0M | $54.5M | ||
| Q2 25 | $119.5M | $43.9M | ||
| Q1 25 | $226.7M | $5.1M | ||
| Q4 24 | $686.3M | $59.3M | ||
| Q3 24 | $188.1M | $73.8M | ||
| Q2 24 | $144.7M | $41.2M | ||
| Q1 24 | $187.3M | $23.8M |
自由现金流ACTCORT
| Q4 25 | — | $38.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $43.9M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $72.2M | ||
| Q2 24 | — | $40.8M | ||
| Q1 24 | — | — |
自由现金流率ACTCORT
| Q4 25 | — | 19.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 22.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 39.5% | ||
| Q2 24 | — | 24.9% | ||
| Q1 24 | — | — |
资本支出强度ACTCORT
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.0% |
现金转化率ACTCORT
| Q4 25 | — | 1.58× | ||
| Q3 25 | — | 2.77× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
